Beijing, Tianjin, and other places have announced their reporting methods! Investigation and clearance, involving the field of pharmaceutical anti-corruption | Medicine | Beijing Tianjin
Since the beginning of this year, over 150 hospital leaders have been investigated, and a large-scale medical anti-corruption campaign is underway.
On July 28th, a video conference was held in Beijing to mobilize and deploy the coordination of disciplinary inspection and supervision agencies in carrying out the centralized rectification of corruption in the national pharmaceutical industry.
Discipline Inspection and Supervision Commissions in Multiple Regions
Shine a Sword at the Intensive Corruption in Medicine
According to the news of "Honest Hegang" on the WeChat official account, according to the unified deployment of the Heilongjiang Provincial Commission for Discipline Inspection and Supervision, on August 9, the mobilization and deployment meeting of Hegang City's discipline inspection and supervision authorities to cooperate in the centralized rectification of corruption in the medical field was held, and arrangements were made to cooperate in the centralized rectification. We need to strengthen the investigation and handling of cases, closely monitor the issue of corruption in the pharmaceutical industry, focus on the "key minority", key positions, and key links, and launch a strong attack and severe punishment to form a strong momentum and effective deterrence for punishing and combating corruption. We must adhere to the joint investigation of bribery and bribery, thoroughly crack down on the network of power and money transactions in the pharmaceutical industry, and eradicate the chain of interests for violations of discipline and law.
On August 8th, a video conference was held in the Greater Khingan Mountains of Heilongjiang Province to mobilize and deploy the coordination of disciplinary inspection and supervision agencies in the entire region to carry out the centralized rectification of corruption in the pharmaceutical industry. This meeting emphasized that the disciplinary inspection and supervision organs in the entire region should integrate the investigation and handling of cases throughout the centralized rectification process. On the basis of achieving phased results in the early investigation and handling of typical cases in the medical field, they should further pressure and thoroughly investigate disciplinary and illegal behaviors such as rent-seeking, interest transfer, and the use of power for personal gain in the medical field, further forming a strong momentum and effective deterrence against corruption and corruption.
In Rizhao, Shandong Province, the Municipal Commission for Discipline Inspection and Supervision held a video conference on August 9th to mobilize and deploy the coordination of disciplinary inspection and supervision agencies in carrying out the centralized rectification of corruption in the medical field throughout the city. The meeting pointed out that we should adhere to the principle of using points to cover all aspects, focus on "key minorities", key personnel in key positions, and key projects, comprehensively strengthen daily supervision, and quickly open up the work situation. We need to comprehensively investigate the clues to the problem, thoroughly investigate the chronic disease of malaria, crack down on bribery, accurately grasp policy strategies, and take the initiative in case investigation and handling to form a strong deterrent.
Announced in multiple parts of the country
Reporting methods for corruption in the pharmaceutical industry
Beijing:
In order to do a good job in the centralized rectification of corruption in the pharmaceutical industry in Beijing, the reporting hotline, email, and information platform during the centralized rectification period will be announced:
Phone: 010-83979279
E-mail jizhongzz@wjw.beijing.gov.cn
Information platform: "Centralized Rectification Clue Collection Platform" on the official website of the Municipal Health Commission
Acceptance time: 9:00-12:00 am and 2:00-6:00 pm on weekdays
Tianjin:
In accordance with the requirements of the national centralized rectification of corruption in the pharmaceutical industry, Tianjin has carried out the centralized rectification of corruption in the pharmaceutical industry. The reporting email is now published as follows:
1、 Rectification time
July 31, 2023 to June 30, 2024
2、 Reporting channels
E-mail tjyfzzb@tj.gov.cn
3、 Related requirements
Complaints and reports must provide clear time, location, department, personnel, specific details, and relevant supporting materials for verification.
The informant shall not fabricate or exaggerate the facts provided by the complaint or report, and shall not intentionally fabricate facts or falsely accuse others. Those who falsely report or falsely accuse and frame others through reporting will be transferred to relevant departments and units in accordance with the law and regulations.
The relevant departments strictly keep confidential the information of the whistleblower. Those who leak information or retaliate against the informant shall be severely punished in accordance with the law and regulations once verified.
Inner Mongolia:
Report hotline: 0471-6946118
Reporting Platform: The official website of the Autonomous Region Health Commission is the "Complaint Reporting Platform"..
Acceptance time: 9:00-12:00 on weekdays, 13:30-17:00.
Chongqing:
Report hotline: 023-67706418.
Acceptance time: Monday to Friday, 9:00-12:30, 14:00-18:00.
Reporting email: cqswjw2023@163.com .
Mailing address: No. 6 Qilong Road, Yubei District, Chongqing City;
Recipient: Special team for centralized rectification work;
Postal code: 401147.
Hainan:
1、 Reporting object
Administrative units, public medical and health institutions, and non-profit social medical and health institutions with license approval and review authority in the pharmaceutical field at all levels and types throughout the province, social organizations that receive management guidance from the administrative departments in the pharmaceutical field, pharmaceutical enterprises, and their associated distributors and pharmaceutical representatives.
2、 Report content
1. Administrative management departments in the pharmaceutical industry participate in activities such as banquets, entertainment, fitness, and tourism that may affect the fair execution of official duties; Reimburse expenses that should be paid by individuals to administrative counterparties and relevant units.
2. Corruption issues related to the sale of drugs, equipment, and consumables with gold.
3. Social organizations that receive guidance from administrative departments in the field of medicine are forced to charge for services, only charge for services without providing them, and engage in disguised distribution under the guise of "donations" or participation in conferences.
4. Issues related to the use of drugs, medical consumables, diagnosis and treatment projects in the medical insurance fund.
5. The behavior of pharmaceutical production and operation enterprises providing kickbacks to medical institutions, their internal departments, and employees under various pretexts or forms such as consulting fees, lecture fees, and promotion fees.
6. The issue of medical personnel violating the "Nine Guidelines for Clean and Honest Employment of Medical Institution Staff".
3、 Reporting platform
1. Reporting hotline: 0898-65311519;
2. Reporting email: hnwjwjgjw@163.com ;
3. Online reporting: Haiyiban - Hainan Health Island - Medical Conduct Reporting;
4. Reporting address: Room 320, 3rd Floor, Haifu Office Building, Provincial Government, No. 59 Meilan District, Haikou City.
Yunnan:
Reporting method:
Telephone method
Yunnan Provincial Health Commission: 0871-67199319.
Received calls from August 2023 to the end of May 2024, every Monday to Friday from 9:00 to 12:00, and from 14:30 to 18:00.
Mailing method
Room 502, Zhengtong Building, No. 309 Guomao Road, Kunming City, Yunnan Province, Postal Code: 650200.
YNYYLYFB@126.com .
Visiting reception location
Room 505, Unit 6, Room 702, Yunnan Provincial Health Commission;
Reception time: From August 2023 to the end of May 2024, every Monday to Friday from 9:00 to 12:00, and from 14:30 to 18:00.
Sichuan
Report hotline: 028-86153707
Reporting email: scwjhfb2023@126.com
Mailing address: Medical Administration and Management Office of the Provincial Health Commission, No. 39 Shangwangjiaguai Street, Chengdu City, postal code: 610041.
Shanxi:
In order to further strengthen the construction of professional ethics in the healthcare sector throughout the province and rectify corruption in the pharmaceutical sector, the hotline and email address for reporting professional ethics in the healthcare sector throughout the province are now announced:
Phone: 0351-3580402
E-mail sxyylyzz@126.com
Fujian:
In order to further strengthen the construction of professional ethics in the healthcare sector throughout the province and rectify corruption in the pharmaceutical sector, the hotline and email address for reporting professional ethics in the healthcare sector throughout the province are now announced:
Phone: 0591-8782483
E-mail fjyylyzz@126.com
Multi regional medicine
The People's Hospital of Chongzuo City, Guangxi issued a notice in April this year regarding the visit of medical representatives to medical personnel, which stipulated the reception time, reception location, reception management, and other aspects.
The announcement clearly states that pharmaceutical representatives need to register and file, and should provide materials such as a letter of commitment to integrity stamped with the company's official seal. In addition, the reception department should follow the requirements of "three confirmations and three musts", namely "fixed appointment and appointment", "appointment and process with records" for reception. In principle, there should be no less than 2 people present at the reception, including visiting department directors or medical staff, as well as at least 1 staff member from the responsible department or supervision room. If necessary, the responsible leader or dean can be invited to attend. During reception, the person in charge of the visiting department shall keep a record of the reception, and prepare the disciplinary inspection and supervision sampling process and records for the hospital.
The above announcement also mentioned that it is strictly prohibited for any department or individual to receive medical representatives without permission, and medical representatives are not allowed to enter the department without permission to carry out related product promotions, promotions, and other activities. Hospitals are installing high-definition video surveillance equipment in key areas, with surveillance footage retained for 90 days, and so on.
At the same time, public reports show that the special clearance work for unreasonable remuneration has been gradually carried out in some areas.
For example, according to multiple media reports, recently, a document titled "Implementation Plan for Guangxi Zhuang Autonomous Region People's Hospital to Deepen the Special Removal of Unreasonable Remuneration" was widely circulated in the industry. The above-mentioned online documents mentioned that all medical staff in the hospital must actively refund unreasonable remuneration such as lecture fees, training fees, and seminar fees received from 2018 to May 2023. The clearance work will end on July 31st.
The anti-corruption work of similar hospitals is not limited to Guangxi. China News Finance reporter learned from multiple industry insiders that similar work has also been carried out in some public hospitals in Shenyang. According to other media reports, several large hospitals in Guangdong have also begun to prohibit doctors from attending meetings organized by manufacturers and investigating lecture fees.
The Discipline Inspection Commission and Supervision Commission of Pizhou City, Jiangsu Province, urge public hospitals to improve the supervision and restraint mechanism for key positions such as pharmacy, finance, and procurement management, implement a review and filing registration system for pharmaceutical representatives, sign a clean purchase and sales agreement, and use big data to establish a prescription spot check mechanism to avoid excessive purchase and abuse of expensive drugs.